Press "Enter" to skip to content

Tiny Drop Of Blood Could Help Cure Alzheimer’s Disease

People are spending billions of dollars on cancer treatment to put a complete end to it. The fundamental goal of scientists at Rush University Medical Center is to develop the most efficient, cost-effective, and foolproof technology for cancer therapy. The devastating disease is in urgent need for an effective treatment just like the neurodegenerative disease, Alzheimer’s. This neurodegenerative disease has killed more people compared to aggressive cancers like prostate cancer and breast cancer. Till date, no drug has been found to help slow the disease. The costs related to Alzheimer’s and other dementia care and research has reached $290 Billion. If no effective cure is found by 2050 then the cost may increase up to $1.1 Trillion. In the US, around 5.8 Million Americans have been found to have Alzheimer’s and it is found to reach 14 Million by 2050.

Researchers have found a blood test to help screen for early signs of Alzheimer’s disease and other forms of dementia. The small drop of blood is enough to get hold of the deadly disease. This new revolutionary technique can help provide necessary care on a timely basis. There are many providing dozens of research but the one provided a Japanese group in 2018 was found to be 88% accurate. The clinical studies have shown many drugs and therapies to fail badly. The simple test can help develop a warning system that is much needed before the onset of the disease.

The simple blood test could become an alternative for the presently used costly, invasive brain scans and intricate spinal fluid extractions. The disease is found to take years to set in and thus, the Americans are on a lookout for techniques that can identify the gene tied to the disease in an individual. In a similar junction, Dr. Lea Grinberg from the University of California, San Francisco (UCSF) have found the tau protein to accelerate wakefulness degeneration rather than amyloid protein during the early stage of the disease. Thus, excessive napping is found to be a sign for the early onset of Alzheimer’s disease.

Brent Schmidt
Brent Schmidt Subscriber
Managing Editor At Daily Market Journal

Brent accomplished Doctor of Medicine Degree and started his career in the Health domain as a successful practitioner. However, his interest in connecting and educating people while continuing his present work motivated him to write articles on the Daily Market Journal news platform. He is a key member in our team of expert writers with a strong experience of 6 years in the Health sector. Despite his busy schedule, Brent spares time to write blogs for Daily Market Journal’s Health section on a regular basis. Although he holds a strong background of education and experience, Brent is a soft-spoken person and acclaimed as a great storyteller.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *